164 related articles for article (PubMed ID: 29088832)
1. Immunohistochemistry cannot replace DNA analysis for evaluation of
Szymonek M; Kowalik A; Kopczyński J; Gąsior-Perczak D; Pałyga I; Walczyk A; Gadawska-Juszczyk K; Płusa A; Mężyk R; Chrapek M; Góźdź S; Kowalska A
Oncotarget; 2017 Sep; 8(43):74897-74909. PubMed ID: 29088832
[TBL] [Abstract][Full Text] [Related]
2. Specific immunohistochemical detection of the BRAF V600E mutation in primary and metastatic papillary thyroid carcinoma.
Zhu X; Luo Y; Bai Q; Lu Y; Lu Y; Wu L; Zhou X
Exp Mol Pathol; 2016 Feb; 100(1):236-41. PubMed ID: 26795218
[TBL] [Abstract][Full Text] [Related]
3. An affordable immunohistochemical approach to estimate the prevalence of
Choden S; Keelawat S; Jung CK; Bychkov A
Gland Surg; 2020 Oct; 9(5):1867-1877. PubMed ID: 33224862
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Immunohistochemistry and Direct Sanger Sequencing for Detection of the BRAF(V600E) Mutation in Thyroid Neoplasm.
Oh HS; Kwon H; Park S; Kim M; Jeon MJ; Kim TY; Shong YK; Kim WB; Choi J; Kim WG; Song DE
Endocrinol Metab (Seoul); 2018 Mar; 33(1):62-69. PubMed ID: 29388401
[TBL] [Abstract][Full Text] [Related]
5. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.
Zimmermann AK; Camenisch U; Rechsteiner MP; Bode-Lesniewska B; Rössle M
Cancer Cytopathol; 2014 Jan; 122(1):48-58. PubMed ID: 24039206
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of immunohistochemistry for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma: comparative analysis with three DNA-based assays.
Ilie MI; Lassalle S; Long-Mira E; Bonnetaud C; Bordone O; Lespinet V; Lamy A; Sabourin JC; Haudebourg J; Butori C; Guevara N; Peyrottes I; Sadoul JL; Bozec A; Santini J; Capper D; von Deimling A; Emile JF; Hofman V; Hofman P
Thyroid; 2014 May; 24(5):858-66. PubMed ID: 24417277
[TBL] [Abstract][Full Text] [Related]
7. VE1 Immunohistochemistry Improves the Limit of Genotyping for Detecting
Choden S; Keelawat S; Jung CK; Bychkov A
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32150939
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry is highly sensitive and specific for detecting the BRAF V600E mutation in papillary thyroid carcinoma.
Sun J; Zhang J; Lu J; Gao J; Lu T; Ren X; Duan H; Liang Z
Int J Clin Exp Pathol; 2015; 8(11):15072-8. PubMed ID: 26823846
[TBL] [Abstract][Full Text] [Related]
9. VE1 immunohistochemistry is an adjunct tool for detection of BRAF
Rashid FA; Tabassum S; Khan MS; Ansari HR; Asif M; Sheikh AK; Sameer Aga S
J Clin Lab Anal; 2021 Feb; 35(2):e23628. PubMed ID: 33305405
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma.
Zagzag J; Pollack A; Dultz L; Dhar S; Ogilvie JB; Heller KS; Deng FM; Patel KN
Surgery; 2013 Dec; 154(6):1199-204; discussion 1204-5. PubMed ID: 23931769
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of the BRAF V600E mutation in papillary thyroid carcinoma. Evaluation against real-time polymerase chain reaction.
Paja Fano M; Ugalde Olano A; Fuertes Thomas E; Oleaga Alday A
Endocrinol Diabetes Nutr; 2017 Feb; 64(2):75-81. PubMed ID: 28440781
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry is a feasible method to screen BRAF V600E mutation in colorectal and papillary thyroid carcinoma.
Zhang X; Wang L; Wang J; Zhao H; Wu J; Liu S; Zhang L; Li Y; Xing X
Exp Mol Pathol; 2018 Aug; 105(1):153-159. PubMed ID: 30009773
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma.
Jung YY; Yoo JH; Park ES; Kim MK; Lee TJ; Cho BY; Chung YJ; Kang KH; Ahn HY; Kim HS
Pathol Res Pract; 2015 Feb; 211(2):162-70. PubMed ID: 25468810
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Immunohistochemistry and Direct Sequencing Methods for Identification of the BRAF
Kim JK; Seong CY; Bae IE; Yi JW; Yu HW; Kim SJ; Won JK; Chai YJ; Choi JY; Lee KE
Ann Surg Oncol; 2018 Jun; 25(6):1775-1781. PubMed ID: 29611028
[TBL] [Abstract][Full Text] [Related]
15. Investigation of BRAF V600E detection approaches in papillary thyroid carcinoma.
Chen D; Qi W; Zhang P; Zhang Y; Liu Y; Guan H; Wang L
Pathol Res Pract; 2018 Feb; 214(2):303-307. PubMed ID: 29254799
[TBL] [Abstract][Full Text] [Related]
16. Utilization of a MAB for BRAF(V600E) detection in papillary thyroid carcinoma.
Bullock M; O'Neill C; Chou A; Clarkson A; Dodds T; Toon C; Sywak M; Sidhu SB; Delbridge LW; Robinson BG; Learoyd DL; Capper D; von Deimling A; Clifton-Bligh RJ; Gill AJ
Endocr Relat Cancer; 2012 Dec; 19(6):779-84. PubMed ID: 22997209
[TBL] [Abstract][Full Text] [Related]
17. A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer.
Martinuzzi C; Pastorino L; Andreotti V; Garuti A; Minuto M; Fiocca R; Bianchi-Scarrà G; Ghiorzo P; Grillo F; Mastracci L
Endocrine; 2016 Sep; 53(3):672-80. PubMed ID: 26296380
[TBL] [Abstract][Full Text] [Related]
18. Comparison of droplet digital PCR and direct Sanger sequencing for the detection of the BRAF
Wang Z; Sun K; Jing C; Cao H; Ma R; Wu J
J Clin Lab Anal; 2019 Jul; 33(6):e22902. PubMed ID: 31021028
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of immunohistochemistry to detect BRAF V600E mutant protein in thyroid tissues.
Zhang Y; Liu L; Liu Y; Cao N; Wang L; Xing C
Medicine (Baltimore); 2021 Apr; 100(16):e25566. PubMed ID: 33879712
[TBL] [Abstract][Full Text] [Related]
20. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.
Lee ST; Kim SW; Ki CS; Jang JH; Shin JH; Oh YL; Kim JW; Chung JH
J Clin Endocrinol Metab; 2012 Jul; 97(7):2299-306. PubMed ID: 22500044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
